Cancer and Leukemia Group B: RPCI/SUNYAB

癌症和白血病 B 组：RPCI/SUNYAB

• 批准号: 7477171
• 负责人: ELLIS G LEVINE
• 金额: $ 27.68万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-04-15 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7477171
• 关键词: Admission activity; Beds; Buffaloes; Cancer and Leukemia Group B; Clinical; Clinical Data; Country; Data; Data Quality; Development; Future; Goals; Grant; Group Meetings; Group Processes; Hospitals; Inpatients; Malignant Neoplasms; Outpatients; Patients; Performance; Phase; Pilot Projects; Protocols documentation; Publications; Research; Resources; Role; Roswell Park Cancer Institute; Science; Services; Standards of Weights and Measures; Visit; experience; foot; member; programs; statistics

DESCRIPTION (provided by applicant): Roswell Park Cancer Institute (RPCI) is requesting support to continue its participation in the Cancer and Leukemia Group B (CALGB). The goals of our participation in CALGB include the following: (1) to continue our strong contribution to the scientific agenda of the Group, (2) to continue our performance of pilot activity at the local level that can be considered for Group adaptation, (3) to continue our administrative support for the efficient functioning of the Group, (4) to sustain accrual in order to allow the rapid accumulation of clinical data and experience through the cooperative group process, and (5) to continue to provide data of high quality in a timely manner. Over the last grant period, we have contributed substantially to the scientific, administrative, core, and publication activities of the CALGB. More specifically, 4 RPCI members serve or have served as chairs or vice chairs of scientific committees; 18 serve or have served as members on 17 scientific committees; 7 serve or have served as study chairs on 12 protocols; 4 have protocols under consideration, and 5 have served as study co-chairs; 4 provide or have provided core services to the Group; and 7 have performed pilot studies that have led to the development of CALGB protocols. RPCI members have contributed to >50 publications and given 16 educational sessions. Furthermore, six members have administrative roles in the Group. RPCI also represents an ongoing resource of ideas for future CALGB science; RPCI has a vigorous Phase I/II program with many protocols potentially exportable to the Group. Accrual is customarily between 200-250 credits/year. Data quality and timeliness of submission has met Group standards. The campus spans 25 acres in downtown Buffalo and consists of 10 research and clinical buildings with approximately one million square feet of space. Statistics for fiscal year 2000-2001 include 8407 new cancer cases, 4000 hospital admissions, and 130,680 outpatient visits from patients in 42 states and 22 foreign countries. Both the inpatient beds and the outpatient centers are located in a spacious facility that opened in 1998.

描述（由申请人提供）：罗斯威尔公园癌症研究所（RPCI）要求支持继续参与癌症和白血病B组（CALGB）。我们参与CALGB的目标包括以下内容：（1）继续我们对小组的科学议程做出的巨大贡献，（2）继续我们在地方一级的飞行员活动进行表现，可以考虑进行小组适应，（3）继续我们的行政支持，以继续我们的行政服务，以维持该小组的有效运行，以继续进行临床数据，并通过临床数据进行临床数据和经验，（4），（4）通过临床数据和经验，（4）进行临床数据的经验，（4）高质量及时。在上一个赠款期间，我们为CalgB的科学，行政，核心和出版活动做出了重大贡献。更具体地说，有4位RPCI成员担任或担任科学委员会主席或副主席； 18或曾担任17个科学委员会成员； 7服务或曾用作12个方案的学习椅； 4有考虑的方案，有5个已担任研究联合主席； 4向小组提供或提供核心服务；有7项进行了试点研究，导致了CALGB方案的发展。 RPCI成员为50个出版物做出了贡献，并进行了16次教育课程。此外，六个成员在小组中担任行政角色。 RPCI还代表了未来Calgb科学的持续思想资源； RPCI具有一个有力的I/II期计划，该计划具有许多可能出口到该组的方案。应计的时间通常在200-250个学分之间。数据质量和提交的及时性已符合小组标准。该校园占地25英亩，位于布法罗市中心，由10座研究和临床建筑组成，大约有100万平方英尺的空间。 2000-2001财政年度的统计数据包括8407例新癌症病例，4000例住院入院以及42个州和22个国外患者的130,680例门诊就诊。住院床和门诊中心都位于1998年开业的宽敞设施中。